Tag: Teva TEV-749 effectiveness study
Teva’s TEV-749 Shows Promising Results in Phase 3 Schizophrenia Study
Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries, recently shared positive results from the Phase 3 SOLARIS trial of TEV-‘749 (olanzapine) for treating...